Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone LossJames R. Berenson, Regina A. Swift, Ori Yellin et al.|Clinical Cancer Research|2008Cited by 70
Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myelomaJames R. Berenson, Robert Vescio, Daisy Martinez et al.|British Journal of Haematology|2022Cited by 12
Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple MyelomaJames R. Berenson, Robert Vescio, Daisy Martinez et al.|Blood|2022Cited by 2
A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and MethylprednisoloneJames R. Berenson, Robert Vescio, Andrea Limon et al.|Targeted Oncology|2024Cited by 2
Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple MyelomaJames R. Berenson, Robert Vescio, Daisy Martinez et al.|Blood|2021Cited by 1